Physician profile
Javier A Roca
NPI 1609958313
$1,340.99
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,032 · 2020: $172 · 2021: $111 · 2022: $25.58.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $250.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $222.06 | 2019 | |
| Incyte Corporation | $198.00 | 2020-2021 | |
| Exelixis INC. | $137.59 | 2019 | |
| Genzyme Corporation | $126.64 | 2019 | |
| Seagen INC. | $111.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $90.51 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $85.49 | 2019-2020 | |
| Ethicon US, LLC | $34.37 | 2019 | |
| Epizyme, INC. | $25.58 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.20 | 2019 | |
| Glaxosmithkline, LLC. | $14.37 | 2019 | |
| Janssen Biotech, INC. | $14.26 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Javier Roca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.